Karmanos Cancer Institute

55 articles with Karmanos Cancer Institute

• 

  Several Players Begin 2022 with New Partnerships in Place

  1/5/2022

  ​It's been a busy day for collaboration announcements in the life sciences world. Here are some of the top stories for today.
• 

  Highlights from American Society of Hematology 2021 Meeting

  12/14/2021

  The 63rd ASH Annual Meeting and Exposition is wrapping up today, with dozens providing updates on clinical trials and preclinical research. Here’s a highlight of just a few of those stories.

• KSP Specialty Pharmacy now offers access to non-oncology drugs and launches new website featuring pharmacy patient portal

  10/4/2021

  The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy are pleased to announce the launch of new services and a new website: www.ksppharmacy.org.

• 

  Veterinary Drug for COVID-19 Patients? Studies Present Confusing Case

  7/8/2021

  Ivermectin has become a contentious issue as to whether it effectively prevents and treats COVID-19. Several studies suggest it is effective, while others have indicated it is not.

• Karmanos Cancer Institute Recognizes March as Colorectal Cancer Awareness Month

  3/1/2021

  The Barbara Ann Karmanos Cancer Institute, along with cancer centers and other organizations across the nation, recognizes March as Colorectal Cancer Awareness Month.

• Black History Month and Cancer Care

  2/1/2021

  bSince 1976, the month of February has been designated as Black History Month in the United States.

• Karmanos Cancer Institute and McLaren Health Care receive first COVID-19 Vaccines to Protect Health Care Professionals

  12/17/2020

  As a part of McLaren Health Care, the Barbara Ann Karmanos Cancer Institute began the process of immunizing its health care workers against COVID-19.

• Karmanos Cancer Institute to implement OncoLens virtual tumor board and cancer treatment planning software solutions

  11/30/2020

  Karmanos Cancer Institute is pleased to announce that it will begin using the OncoLens cancer treatment planning software platform to hold tumor boards and multidisciplinary case discussions.

• Karmanos Cancer Institute launches clinical trials study information portal

  11/13/2020

   Karmanos Cancer Institute is pleased to announce the launch of a new clinical trials study information portal (SIP) on Karmanos.org. This portal was launched on Monday, November 9, 2020 . The SIP websit

• Karmanos Specialty Pharmacy (KSP) receives full, three-year accreditation from the Utilization Review Accreditation Commission (URAC)

  8/20/2020

  Karmanos Specialty Pharmacy is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission.

• Karmanos Cancer Institute Launches COVID-19, Cancer & Community Survey to Assess the Impact of COVID-19 Response on the Health Habits of Michiganders

  6/26/2020

  Karmanos Cancer Institute has launched a survey to ask community members about their experiences with health care during the COVID-19 pandemic. Questions will focus specifically on cancer prevention, screening and treatment, as well as COVID-19 concerns, social distancing and impacts on diverse communities. The survey will enroll 2,000 parti

• Karmanos Cancer Institute Resumes All Services as Cases of COVID-19 Decline and Michigan Governor Lifts Restrictions

  6/1/2020

  As the number of patients who require care for COVID-19 across the state of Michigan decreases and restrictions put in place by the Governor are lifted, Karmanos Cancer Institute continues to offer all cancer care services.

• Shari Ferber Kaufman joins Karmanos Cancer Institute Board of Directors

  2/13/2020

  DETROIT , Feb. 13, 2020 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute (KCI) is pleased to announce the election of Shari Ferber Kaufman to its Board of Directors. Kaufman will serve a three-year term. In her role, Kaufman will collaborate with other board members to support the Institute's mission of leading transformativ

• Karmanos Cancer Institute Issues Statement On E-Cigarettes And Risk Of Vaping

  9/4/2019

  The vaporized ingredients in e-cigarettes, including flavoring products, are potentially harmful and have recently been linked to acute lung injury, chronic respiratory symptoms and even death.

• Karmanos Cancer Institute Wins Federal Grant Renewal For Membership In Prestigious Prostate Cancer Clinical Trials Consortium

  5/23/2017

• Karmanos Cancer Institute Now Offering New Technology To Detect Prostate Cancer

  3/20/2017

• Karmanos Cancer Institute's 23rd Annual Partners Events Support Cancer Research; Honor Philanthropists Linda Dresner And Ed Levy, Jr.

  8/2/2016

• Ann Schwartz, Ph.D., Of Karmanos Cancer Institute In Detroit Elected To International Lung Cancer Consortium Steering Committee

  6/21/2016

• Karmanos Cancer Institute's 34th Annual Dinner April 16 Rolls Out The Red Carpet For Gala At Michigan Motion Picture Studios

  4/7/2016

• Karmanos Cancer Institute Announces Promotions Of Scientific Members

  3/18/2016